Tuis000105 • KRX
add
Yuhan Corp Preference Shares
Vorige sluiting
₩106 100,00
Dagwisseling
₩105 600,00 - ₩107 700,00
Jaarwisseling
₩91 600,00 - ₩129 400,00
Markkapitalisasie
9,67 bn KRW
Gemiddelde volume
6,55 k
P/V-verhouding
116,53
Dividend-opbrengs
0,47%
Marknuus
MarketScreener
1 uur gelede
Intuit CFO Sandeep Aujla to Present at the Nasdaq 53rd Investor Conference
1,90%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (KRW) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 570,01 mjd | -4,80% |
Bedryfskoste | 146,43 mjd | -24,03% |
Netto inkomste | 25,28 mjd | -32,44% |
Netto winsgrens | 4,44 | -28,96% |
Wins per aandeel | 348,00 | -30,26% |
EBITDA | 40,00 mjd | -36,49% |
Effektiewe belastingkoers | 39,83% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (KRW) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 387,12 mjd | 55,47% |
Totale bates | 3,05 bn | 4,35% |
Totale aanspreeklikheid | 836,23 mjd | 11,32% |
Totale ekwiteit | 2,22 bn | — |
Uitstaande aandele | 74,76 m | — |
Prys om te bespreek | 3,68 | — |
Opbrengs op bates | 1,81% | — |
Opbrengs op kapitaal | 2,15% | — |
Kontantvloei
Netto kontantverandering
| (KRW) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 25,28 mjd | -32,44% |
Kontant van bedrywe | 76,86 mjd | 750,62% |
Kontant van beleggings | -27,54 mjd | 44,98% |
Kontant van finansiering | -26,38 mjd | -294,03% |
Netto kontantverandering | 24,40 mjd | 149,60% |
Beskikbare kontantvloei | 42,19 mjd | 150,79% |
Meer oor
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
HUB
Gestig
1926
Webwerf
Werknemers
2 067
